hackint0sh/New-Dataset huggingface dataset:
nctId: NCT06373315 id: 2023/11-18 briefTitle: The Effect of Smartphone and Hand Anthropometry on Pain and Upper Extremity Functions overallStatus: NOT_YET_RECRUITING date: 2024-05-02 date: 2024-06-30 date: 2025-05-02 date: 2024-04-18 date: 2024-04-18 name: Nigde Omer Halisdemir University class: OTHER briefSummary: Mobile phones have different uses in different disciplines, and this encourages long-term use. For optimum comfort use, it is important to ensure users' awareness when purchasing mobile phones that match their hand sizes. The number of studies in the literature on this subject is limited. In this context, the aim of our study is to investigate the relationship between smartphone and hand anthropometry measurements and upper extremity pain and functions. conditions: Upper Extremity Problem conditions: Smartphone Addiction studyType: OBSERVATIONAL observationalModel: OTHER timePerspective: CROSS_SECTIONAL count: 90 type: ESTIMATED measure: Hand anthropometric measurements: Hand length measure: Hand anthropometric measurements: Palm length measure: Hand anthropometric measurements: Width of the hand (Metacarpal) measure: Hand anthropometric measurements: Maximum hand spread measurement measure: Gross grip strength measurement measure: Pinch grip strength measure: Measurement of phone dimensions measure: Upper extremity functional status assessment measure: Pain assessment measure: Smartphone addiction sex: ALL minimumAge: 18 Years maximumAge: 65 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Nigde Omer Halisdemir University, Bor Faculty of Health Sciences city: Niğde state: Nigde zip: 51700 country: Turkey name: Feyza Altindal Karabulut, Assoc. Prof. role: CONTACT phone: +905056263833 email: fztfyz@gmail.com lat: 37.96583 lon: 34.67935 hasResults: False
nctId: NCT06373302 id: IRAS 323948 briefTitle: Peripheral Arterial Disease Biomarkers acronym: PADBIRD overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2024-12-31 date: 2026-12-31 date: 2024-04-18 date: 2024-04-18 name: Norfolk and Norwich University Hospitals NHS Foundation Trust class: OTHER briefSummary: The study aims to determine how expression levels of biomarkers for peripheral arterial disease change over time in response to exercise therapy, surgical or endovascular intervention, and whether they can be used to predict disease progression. conditions: Peripheral Arterial Disease studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: OTHER count: 100 type: ESTIMATED measure: Correlation between PAD biomarker levels and walking distance. measure: Change in PAD biomarker levels following exercise therapy. measure: Change in PAD biomarker levels following endovascular intervention measure: To determine whether biomarker levels normalise with improved walking distance. measure: To determine whether biomarker levels can be used as a predictor of restenosis, occlusion or reintervention following endovascular intervention. measure: Levels of biomarkers and (Major Adverse Cardiovascular Events). sex: ALL minimumAge: 50 Years maximumAge: 99 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06373289 id: 000539476 id: 1K23HD113837-01A1 type: OTHER domain: NICHD (pending) briefTitle: Target Oxygen Ranges in Infants With Pulmonary Hypertension acronym: TORPH overallStatus: NOT_YET_RECRUITING date: 2025-07-01 date: 2029-07-01 date: 2030-07-01 date: 2024-04-18 date: 2024-04-18 name: University of Alabama at Birmingham class: OTHER briefSummary: Around 50% of infants born extremely preterm develop a chronic lung disease known as bronchopulmonary dysplasia of which some infants will also develop pulmonary hypertension of which 50% of children will die before the age of 2. Physicians are currently limited in their ability to select the most appropriate oxygen targets that will improve outcomes in infants with this condition. This clinical trial will determine whether using different amounts of oxygen improve outcomes in infants with this disease. conditions: Bronchopulmonary Dysplasia conditions: Pulmonary Hypertension studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: CROSSOVER interventionModelDescription: Single center, randomized cross-over pilot study with a 1:1 parallel allocation of infants to SpO2 targets of 92-95% (control) and 95-98% (intervention) using a stratified permuted block design. Following 2 weeks of exposure A, infants will cross over to exposure B for 2 weeks with a 1-week washout period. primaryPurpose: TREATMENT masking: SINGLE maskingDescription: The PI will perform bedside echocardiography precluding masking to group allocation. All echocardiograms will be further reviewed by a cardiologist masked to group allocation with additional cardiologist review in instances of disagreement. Inter-rater reliability testing will also be performed. whoMasked: OUTCOMES_ASSESSOR count: 39 type: ESTIMATED name: higher oxygen saturation target using Nellcor pulse oximetry sensors name: lower oxygen saturation target using Nellcor pulse oximetry sensors measure: Intermittent hypoxemia event duration measure: Echocardiographic shunting measure: Echocardiographic interventricular septal flattening measure: Echocardiographic tricuspid regurgitation measure: Intermittent hypoxemia frequency measure: Cumulative hypoxemia measure: Brain natriuretic peptide sex: ALL minimumAge: 2 Months maximumAge: 5 Months stdAges: CHILD hasResults: False
nctId: NCT06373276 id: 1511 briefTitle: The Effects of a Home-Based Fall Prevention Program on Community-Dwelling Elderly's Fall Risk Category overallStatus: RECRUITING date: 2024-01-15 date: 2024-04 date: 2024-05 date: 2024-04-18 date: 2024-04-18 name: Dilshaad Basrai Vad class: OTHER briefSummary: The primary goal of this dissertation study is to determine if a home-based multiplanar balance training program with electronic assistance, will be effective in reducing one's fall risk category.
Hypothesis: After 12 weeks, there will be a statistically significant decrease in the fall risk category for individuals in a home-based multiplanar balance training and educational program with electronic assistance as compared to no change in the fall risk category for individuals in an educational control group with electronic assistance Hypothesis: To determine if an individual's fear of falling is lower following a home-based multiplanar balance training and educational program, with electronic assistance as compared to no change in fear of falling following an educational control group with electronic assistance post-intervention.
Hypothesis: There will be a statistically significant inverse relationship between an individual's fear of falling and their fall risk category. conditions: Fall Risk studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Participants in the multiplanar balance training home-based exercise and educational group (group A) will have a video, as well as written instructions, of the intervention and dosage, along with the five educational brochures loaded on their phone via the SAFE beta app. In the SAFE beta app, the participants will be prompted daily to click on the beta app to watch the demonstration of the interventional exercise. They are then prompted to begin their daily prescriptive intervention, which is a 7-day-a-week program for 12 weeks. Participants can view a video of the exercise intervention in real-time in order to "mirror" the exercises as they are completing the exercises. primaryPurpose: PREVENTION masking: SINGLE maskingDescription: The primary investigator, who delivers the treatment, is blinded to to the performance outcome measures. whoMasked: INVESTIGATOR count: 70 type: ESTIMATED name: multiplanar balance training exercise with education name: education only measure: Timed up and Go Test measured in Seconds measure: 3 stage balance test measured in seconds measure: 30-second chair stand measured in repeitions sex: ALL minimumAge: 65 Years stdAges: OLDER_ADULT facility: Metro PT status: RECRUITING city: New York state: New York zip: 10021 country: United States name: dilshaad vad, DPT role: CONTACT phone: 917-478-2444 email: dilshaad.vad@gmail.com name: Lior Cohen, DPT role: CONTACT phone: 9175549511 lat: 40.71427 lon: -74.00597 hasResults: False
nctId: NCT06373263 id: 2024-4165 briefTitle: Evaluating Tools to Communicate Scleroderma Research Results to Patients acronym: SPIN-KT overallStatus: NOT_YET_RECRUITING date: 2024-06 date: 2024-06 date: 2024-06 date: 2024-04-18 date: 2024-04-18 name: Lady Davis Institute class: OTHER briefSummary: Sharing research results with patients is required by ethical regulations. Yet, most researchers do not share results from their studies with patients. The investigators plan to conduct a series of randomized controlled trials among people with scleroderma, a rare autoimmune disease, in a large international cohort, to identify the most effective methods for communicating study results with patients.
The first trial in the series will compare a research dissemination tool (infographic) against a plain-language summary comparator. Participants will be randomly assigned to receive the dissemination tool or comparator. Study participants will rate communication tools for (1) information completeness; (2) understandability; and (3) ease of use of format. Our results can be used by researchers and patient organizations who disseminate research results so that they can tailor the way they disseminate results to patient needs. conditions: Scleroderma conditions: Systemic Sclerosis studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Parallel Assignment primaryPurpose: OTHER masking: NONE count: 488 type: ESTIMATED name: Plain-language summary name: Dissemination Tool (Infographic) measure: Completeness measure: Understandability measure: Ease of use measure: Please to have received results measure: Intention to participate in future studies measure: Open-ended items sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06373250 id: sdilek7 briefTitle: Maternal Consequences of Membrane Stripping overallStatus: RECRUITING date: 2024-04-11 date: 2024-10-11 date: 2024-11-11 date: 2024-04-18 date: 2024-04-18 name: Kocaeli University class: OTHER briefSummary: This study aims to investigate the maternal effects of membrane stripping during vaginal birth. This study was designed as an experimental case-control study. The sample size in the study was determined by Njoku et al in 2023 to assess the effectiveness of membrane stripping applied to participants who had vaginal birth in reducing the incidence of prolonged pregnancy. Calculated based on the study conducted by. The sample size of the study was calculated using G\*Power 3.1.9.2, and the mean and standard deviation of the Bishop score in the relevant article were used to calculate the effect size. Using the mean and standard deviation of the relevant article, the blended effect size was calculated as 0.596. The minimum number of individuals that should be included in the sample of this research was calculated using G\*Power 3.1.9.2, effect size: 0.596, α= 0.05, power: 0.95 (stripping = 70, control = 70) and at least in each group in the sample size. The sample size was set at 70 participants. The research data will be collected by the researcher using the Informed Volunteer Consent Form, Participant Information Form, Bishop Scoring, Visual Analogue Scale, and Birth Satisfaction Scale Short Form, which were created by the researcher within the framework of the literature on the subject. conditions: Maternal Care for Other Abnormalities of Cervix studyType: INTERVENTIONAL phases: NA allocation: NON_RANDOMIZED interventionModel: PARALLEL primaryPurpose: SUPPORTIVE_CARE masking: NONE count: 140 type: ESTIMATED name: Membrane stripping group name: Control group measure: Visual analogue scale evaluation of vaginal examination pain measure: Visual analogue scale evaluation of vaginal examination pain measure: Evaluation of the cervix with Bishop score measure: Evaluation of the amount of bleeding measure: Birth Satisfaction Scale Short Form sex: FEMALE minimumAge: 18 Years maximumAge: 40 Years stdAges: ADULT facility: Kocaeli University status: RECRUITING city: Kocaeli zip: 41380 country: Turkey name: Burcu Ozturk, M.Sc. role: CONTACT email: 1burcuozturk@gmail.com lat: 39.62497 lon: 27.51145 hasResults: False
nctId: NCT06373237 id: INC-IG-2024-001 briefTitle: Outcome of Embryos Transferred After Initial Chaotic Results on PGT-A overallStatus: ACTIVE_NOT_RECRUITING date: 2024-03-26 date: 2024-05 date: 2026-05 date: 2024-04-18 date: 2024-04-18 name: Inception Fertility, LLC class: INDUSTRY name: Igenomix briefSummary: This is a retrospective review of treatment outcomes from fertility clinics in The Prelude Network who have used Igenomix for PGT-A and have transferred embryos with initial chaotic results, regardless if re-biopsy was performed. conditions: Infertility studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: RETROSPECTIVE count: 2000 type: ESTIMATED measure: Frequency of embryo re-biopsy measure: Re-biopsy results measure: Embryo disposition measure: Embryo transfer outcome measure: Pregnancy outcome sex: FEMALE stdAges: CHILD stdAges: ADULT stdAges: OLDER_ADULT facility: Inception Fertility LLC city: Houston state: Texas zip: 77081 country: United States lat: 29.76328 lon: -95.36327 hasResults: False
nctId: NCT06373224 id: 23-037 briefTitle: Cold Saline Irrigation Before Endobronchial Biopsy overallStatus: RECRUITING date: 2023-12-01 date: 2024-12-02 date: 2025-02-02 date: 2024-04-18 date: 2024-04-22 name: TriHealth Inc. class: OTHER briefSummary: Patients undergoing an endobronchial ultrasound and biopsy can experience bleeding during the biopsy. These biopsies are read in real time by pathologists who travel to the endoscopy unit during the procedure. Often, when this happens, the blood contaminates the pathology slides making the slide unreadable. This then requires more biopsies to be performed, thus prolonging the procedure, and increasing anesthesia time. One innovative way to reduce bleeding may be to irrigate the bronchial wall with cold saline, where the biopsy is to be taken, immediately before biopsy, thus causing vasoconstriction and possibly resulting in less blood contamination on the biopsy slides. The current study will evaluate this prophylactic irrigation with saline to control bleeding, thus resulting in a quicker diagnostic result of the biopsies. conditions: Lung Diseases studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL primaryPurpose: PREVENTION masking: NONE count: 120 type: ESTIMATED name: Flush measure: Incidence of unreadable biopsy slides sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Bethesda North Hospital status: RECRUITING city: Cincinnati state: Ohio zip: 45242 country: United States name: Rachel Baker, PhD, RN role: CONTACT phone: 513-569-6191 email: Rachel_Baker2@trihealth.com lat: 39.12713 lon: -84.51435 hasResults: False
nctId: NCT06373211 id: APHP230701 id: 2023-506942-22-01 type: OTHER domain: CTIS briefTitle: Early Immunotherapy With Intravenous Immunoglobulin, Cyclophosphamide and Methylprednisolone in Patients With Anti-Hu-associated Paraneoplastic Sensory Neuronopathy acronym: NESPA overallStatus: NOT_YET_RECRUITING date: 2024-06 date: 2027-06 date: 2027-06 date: 2024-04-18 date: 2024-04-18 name: Assistance Publique - Hôpitaux de Paris class: OTHER briefSummary: Paraneoplastic Neurological Syndromes are rare autoimmune complications linked to the presence of systemic cancer. Despite their autoimmune origin, they have historically shown little response to immunotherapy. The reason for this failure is probably related to too late administration of immunotherapy, at a stage where the inflammation has already disappeared and irreversible neuronal loss has occurred. The protocol focuses on patients with anti-Hu antibody sensory neuronopathy. This single arm trial consists of an early immunotherapy combining Intravenous Immunoglobulin (IVIG) for 3 months, cyclophosphamide and methylprednisolone for 6 months, at the rate of 1 cycle per month. The percentage of patients with clinical improvement will be evaluated (ONLS) at 3 months. The tolerance of the treatment will also be evaluated as well as other functional scales at 3 and 6 months. conditions: Paraneoplastic Sensory Neuronopathy studyType: INTERVENTIONAL phases: PHASE2 allocation: NA interventionModel: SINGLE_GROUP primaryPurpose: TREATMENT masking: NONE count: 21 type: ESTIMATED name: Immunoglobulins IV (CLAYRIG) name: Cyclophosphamide IV name: Methylprednisolone IV measure: Percentage of patients with clinical improvement on the ONLS (Overall Neuropathy Limitations Scale) at 3 months measure: Percentage of patients with clinical improvement on the ONLS (Overall Neuropathy Limitations Scale) at 3 and 6 months measure: Percentage of patients with improvement in the ataxic component on the Score of Ataxia scale at 3 and 6 months measure: Percentage of patients with improvement in neuropathic pain on the Numeric Rating Scale (NRS) at 3 and 6 months measure: Percentage of patients with functional improvement on the modified Rankin Score (mRS) at 3 and 6 months measure: Percentage of patients with functional improvement on the Barthel Index (BI) at 3 and 6 months measure: Percentage of patients alive and without tumor progression at 6 months measure: Tolerance to treatment sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT facility: Hôpital Pitié-Salpêtrière city: Paris zip: 75013 country: France name: Dimitri Psimaras, MD role: CONTACT email: dimitri.psimaras@aphp.fr name: Alice LEPRINCE-LAURENGE, MD role: CONTACT email: alice.laurenge@aphp.fr lat: 48.85341 lon: 2.3488 hasResults: False
nctId: NCT06373198 id: 0040/2023-versión 1.0 briefTitle: Implementation of a Re-engagement Program for Hepatitis C Patients Lost to Follow-up in Argentina. overallStatus: NOT_YET_RECRUITING date: 2024-05-01 date: 2024-07-01 date: 2025-01-15 date: 2024-04-18 date: 2024-04-18 name: Hospital El Cruce class: OTHER name: Gilead Sciences briefSummary: Hepatitis C virus (HCV) is a leading cause of morbidity and mortality worldwide. This infection continues to represent a major global public health concern. This is why the introduction of potent antivirals for the treatment of HCV has been one of the major breakthroughs of the current medical era.
From a public health perspective, HCV prevalence will be eliminated if the available treatment also targets those most likely to transmit the virus. Despite this scientific advance, a systematic review from the U.S. described that of the 43% of patients aware of their HCV diagnosis, only 16% started treatment. Clearly, the long-known barriers to accessing this treatment must be broken down in order to administer these effective antivirals. The World Health Organization (WHO) has set the ambitious goal of eliminating viral hepatitis as a public health threat by 2030. This goal is really difficult to achieve, especially in low and middle-income countries. Particularly in Argentina, there is a need to improve diagnosis, access to care, and treatment of viral hepatitis. The prospect of viral hepatitis elimination in our country is daunting due to the complexity of the health system and the cost of implementing different strategies. The most pragmatic approach would be to break down national elimination targets into smaller targets for individual populations, for which treatment and prevention interventions can be delivered more quickly and efficiently. This concept is known as micro-elimination. Focusing on micro-elimination of viral hepatitis means working to achieve the WHO target in specific subpopulations. Subpopulations known to have a higher prevalence of HCV infection include prisoners, people who inject drugs, and patients requiring hemodialysis, among others.
Currently, patient unawareness of HCV infection represents one of the major barriers to treatment. In many cases, the diagnosis of HCV was established many years ago and patients do not seek treatment probably because they do not recognize the urgency of treating this asymptomatic infection. It is our goal, then, to identify the group of individuals who have been diagnosed with HCV infection but are not currently undergoing regular visits with health care professionals. This strategy is now called re-linking to the medical care of patients with chronic HCV. conditions: Hepatitis C Chronic conditions: Hepatitis C studyType: OBSERVATIONAL observationalModel: COHORT timePerspective: PROSPECTIVE count: 800 type: ESTIMATED name: standard of care measure: rate of relinked HCV patients measure: proportion of relinked patients who received antiviral treatment measure: Evaluation and characteristics of the treatment established sex: ALL minimumAge: 18 Years stdAges: ADULT stdAges: OLDER_ADULT hasResults: False
nctId: NCT06373185 id: 2023/21 briefTitle: Comparison of the Efficacy of Sacral Espb and Caudal Block for Pain Management After Urogenital Surgeries in Children acronym: SESPB overallStatus: RECRUITING date: 2024-04-22 date: 2024-05 date: 2024-06 date: 2024-04-18 date: 2024-04-23 name: Giresun University class: OTHER briefSummary: The aim of this study was to compare the efficacy of caudal block and sacral espb used as a postoperative analgesia method in urogenital pediatric surgery cases. conditions: Urogenital Diseases conditions: Nerve Block conditions: Pain, Postoperative studyType: INTERVENTIONAL phases: NA allocation: RANDOMIZED interventionModel: PARALLEL interventionModelDescription: Randomized controlled double blind study primaryPurpose: TREATMENT masking: DOUBLE maskingDescription: Randomisation using a closed envelope method based on computer-generated random numbers was to assign patients to two equal groups. Group 1 received midline US-guided sacral erector spinae plane block and Group 2 received caudal block. The experienced anesthetist who opened the envelope performed the block according to the group code and patients were followed postoperatively by an anesthetist blinded to which block was performed. Patients were also blinded as to which block was performed. whoMasked: PARTICIPANT whoMasked: OUTCOMES_ASSESSOR count: 60 type: ESTIMATED name: Ultrasound-guided sacral erector spinae plane block name: Ultrasound-guided caudal block measure: Face, Leg, Activity, Cry, Consolability (FLACC) score measure: Analgesic requirement measure: Satisfaction of the patient's parents measure: Satisfaction of the surgeons sex: ALL minimumAge: 1 Year maximumAge: 7 Years stdAges: CHILD facility: Giresun Research and Training Hospital status: RECRUITING city: Gi̇resun state: Central zip: 28100 country: Turkey name: Bilge Olgun Keleş role: CONTACT phone: 05317338805 email: bilge.olgun@hotmail.com name: Dilek Yeniay role: CONTACT phone: 05375521553 email: dilekyeniay@hotmail.com lat: 40.91698 lon: 38.38741 hasResults: False
nctId: NCT06373172 id: 202005-HR-003 briefTitle: Enhancing Clinical Reasoning Competency acronym: Reasoning overallStatus: COMPLETED date: 2020-05-01 date: 2020-06-01 date: 2023-03-01 date: 2024-04-18 date: 2024-04-18 name: Tongmyong University class: OTHER briefSummary: Enhancing Clinical Reasoning Competency for Undergraduate Nursing Students Using Virtual Simulation-based Education based on the Rasch model